CoChat

PKC-Dependent Human Monocyte Adhesion Requires AMPK and Syk Activation

Open access

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Abstract

PKC plays a pivotal role in mediating monocyte adhesion; however, the underlying mechanisms of PKC-mediated cell adhesion are still unclear. In this study, we elucidated the signaling network of phorbol ester PMA-stimulated human monocyte adhesion. Our results with pharmacological inhibitors suggested the involvement of AMPK, Syk, Src and ERK in PKC-dependent adhesion of THP-1 monocytes to culture plates. Biochemical analysis further confirmed the ability of PMA to activate these kinases, as well as the involvement of AMPK-Syk-Src signaling in this event. Direct protein interaction between AMPK and Syk, which requires the kinase domain of AMPK and linker region of Syk, was observed following PMA stimulation. Notably, we identified Syk as a novel downstream target of AMPK; AICAR can induce Syk phosphorylation at Ser178 and activation of this kinase. However, activation of AMPK alone, either by stimulation with AICAR or by overexpression, is not sufficient to induce monocyte adhesion. Studies further demonstrated that PKC-mediated ERK signaling independent of AMPK activation is also involved in cell adhesion. Moreover, AMPK, Syk, Src and ERK signaling were also required for PMA to induce THP-1 cell adhesion to endothelial cells as well as to induce adhesion response of human primary monocytes. Taken together, we propose a bifurcated kinase signaling pathway involved in PMA-mediated adhesion of monocytes. PKC can activate LKB1/AMPK, leading to phosphorylation and activation of Syk, and subsequent activation of Src and FAK. In addition, PKC-dependent ERK activation induces a coordinated signal for cytoskeleton rearrangement and cell adhesion. For the first time we demonstrate Syk as a novel substrate target of AMPK, and shed new light on the role of AMPK in monocyte adhesion, in addition to its well identified functions in energy homeostasis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0040999

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 PMA-induced monocyte adhesion is blocked by inhibitors of AMPK, Syk and c-Src. (A) THP-1 cells were incubated with PMA at the concentrations indicated for 4 h (left panel) or for different periods (right panel). (B) Cells were treated with Ro318220, GF109203X, Go6983, Ro320432, or LY333531 at the concentrations indicated for 30 min prior to the addition of PMA and then incubated for another 4 h. (C) All inhibitors at the concentrations indicated were used to pretreat cells 30 min before PMA (10 or 100 nM) incubation for 4 h. Cell adherence was determined by crystal violet staining and quantified by measuring the absorbance at 550 nm. *p<0.05 as compared to the PMA response with vehicle treatment. (D) After PMA (100 nM) treatment for different periods, THP-1 cells were stained with control IgG conjugated with fluorochrome, FITC-conjugated CD11b, or PE-conjugated CD14 antibody for flow cytometry.
Figure 1 PMA-induced monocyte adhesion is blocked by inhibitors of AMPK, Syk and c-Src. (A) THP-1 cells were incubated with PMA at the concentrations indicated for 4 h (left panel) or for different periods (right panel). (B) Cells were treated with Ro318220, GF109203X, Go6983, Ro320432, or LY333531 at the concentrations indicated for 30 min prior to the addition of PMA and then incubated for another 4 h. (C) All inhibitors at the concentrations indicated were used to pretreat cells 30 min before PMA (10 or 100 nM) incubation for 4 h. Cell adherence was determined by crystal violet staining and quantified by measuring the absorbance at 550 nm. *p<0.05 as compared to the PMA response with vehicle treatment. (D) After PMA (100 nM) treatment for different periods, THP-1 cells were stained with control IgG conjugated with fluorochrome, FITC-conjugated CD11b, or PE-conjugated CD14 antibody for flow cytometry.CC BY · PubMed Central
Figure 2 PKC-dependent AMPK and Syk activation mediate Src activation. (A) THP-1 cells were incubated with PMA (100 nM) and the indicated PKC inhibitors for various periods, followed by immunobloting. (B) THP-1 cells were treated with PMA for 15 min; phosphorylation of AMPK and Syk were analyzed by immunofluorescence staining. DAPI staining was used to determine nuclear localization. (C) After drug treatment as indicated, membrane fractions were harvested for immunoblotting of PKCalpha and PKCbeta. To ensure no contamination of fractionation, tubulin and Na/K-ATPase were used as cytosol and membrane controls, respectively. (D) PKC activity was determined as described in Methods. *p<0.05 as compared to the PMA response with vehicle treatment. (E) THP-1 cells were pretreated with inhibitors for 30 min, followed by treatment with PMA (100 nM) for the indicated time intervals, and then immunoblotting of protein phosphorylation on Src (Tyr 419) and c-Src (Tyr 216).
Figure 2 PKC-dependent AMPK and Syk activation mediate Src activation. (A) THP-1 cells were incubated with PMA (100 nM) and the indicated PKC inhibitors for various periods, followed by immunobloting. (B) THP-1 cells were treated with PMA for 15 min; phosphorylation of AMPK and Syk were analyzed by immunofluorescence staining. DAPI staining was used to determine nuclear localization. (C) After drug treatment as indicated, membrane fractions were harvested for immunoblotting of PKCalpha and PKCbeta. To ensure no contamination of fractionation, tubulin and Na/K-ATPase were used as cytosol and membrane controls, respectively. (D) PKC activity was determined as described in Methods. *p<0.05 as compared to the PMA response with vehicle treatment. (E) THP-1 cells were pretreated with inhibitors for 30 min, followed by treatment with PMA (100 nM) for the indicated time intervals, and then immunoblotting of protein phosphorylation on Src (Tyr 419) and c-Src (Tyr 216).CC BY · PubMed Central
Figure 3 PKC induces the LKB1-AMPK-Syk signal pathway. (A) THP-1 cells were treated with inhibitors for 30 min, followed by PMA (100 nM) for the indicated time periods. Immunoblotting using antibodies against AMPK and Syk were conducted. (B–C) After pretreatment with inhibitor for 30 min and PMA treatment for 10 min, cell lysates were immunoprecipitated with Syk antibody. Syk enzymatic activity was determined by autophosphorylation (B) and AMPK association with Syk was determined by immunoblotting (C). (D) After PMA treatment, immunoprecipitation with control IgG, anti-AMPKalpha (upper panel) or anti-LKB1 (lower panel) antibody was subjected to immunoblot analysis with anti-phospho-serine PKC substrate antibody. (E) Immunoblotting with antibodies against phospho-LKB1 and total LKB1 were conducted (upper panel). In some experiments, PKC immunoprecipitates were subjected to immunobloting with LKB antibody (lower panel). (F) THP-1 cells were treated with STO-609 (10 µM) for 30 min, followed by PMA (100 nM) for 30 min. AMPK expression was determined by immunobloting.
Figure 3 PKC induces the LKB1-AMPK-Syk signal pathway. (A) THP-1 cells were treated with inhibitors for 30 min, followed by PMA (100 nM) for the indicated time periods. Immunoblotting using antibodies against AMPK and Syk were conducted. (B–C) After pretreatment with inhibitor for 30 min and PMA treatment for 10 min, cell lysates were immunoprecipitated with Syk antibody. Syk enzymatic activity was determined by autophosphorylation (B) and AMPK association with Syk was determined by immunoblotting (C). (D) After PMA treatment, immunoprecipitation with control IgG, anti-AMPKalpha (upper panel) or anti-LKB1 (lower panel) antibody was subjected to immunoblot analysis with anti-phospho-serine PKC substrate antibody. (E) Immunoblotting with antibodies against phospho-LKB1 and total LKB1 were conducted (upper panel). In some experiments, PKC immunoprecipitates were subjected to immunobloting with LKB antibody (lower panel). (F) THP-1 cells were treated with STO-609 (10 µM) for 30 min, followed by PMA (100 nM) for 30 min. AMPK expression was determined by immunobloting.CC BY · PubMed Central
Figure 4 Binding domains between Syk and AMPK and AMPK-mediated Syk phosphorylation. (A) HEK293T cells were transfected with Myc-AMPKalpha2 and various deletion constructs of Flag-Syk. Cell lysates were immunoprecipitated with anti-Flag antibody and then subjected to immunoblot analysis with anti-Myc or anti-Flag antibody (upper panel). To assess the association of AMPKalpha2 to different deletions of Syk, we quantified the intensity of immunoprecipitated Syk and associated AMPK. Then the level of AMPK/Syk was calculated (shown in parentheses). Internal controls of Myc-AMPKalpha2 and Flag-Syk expression in cell lysates were determined (lower panel). (B) HEK293T cells were transfected with Myc-AMPKalpha2 and Flag-Syk. Immunoprecipitates using Myc antibody were subjected to immunobloting with Flag antibody. (C) Plasmids of Flag-Syk and Myc-AMPKalpha2 with various deletions were transfected into HEK293T cells. Immunoprecipitates with anti-Flag antibody were subjected to immunoblot analysis with anti-Myc and -Syk antibodies. (D) Alignment of the consensus recognition motifs for AMPK and sequences around sites to be phosphorylated by AMPK on physiological substrates. The serine residues phosphorylated were indicated by the arrow. In the consensus recognition motif, Φ refers to a hydrophobic residue and beta to a basic residue. (E) Myc-AMPKalpha2 was expressed with Flag-Syk (WT) or Flag-Syk (S178A) construct in HEK293T. Afterwards, cells were treated with AICAR for 15 or 30 min. Immunoprecipitate with Syk antibody was then subjected to in vitro kinase assay. In some samples, the presence of Myc-AMPKα2 in immunocomplexes was determined by immunobloting with Myc antibody. (F) THP-1 cells were treated as indicated, and immunocomplexes with AMPK antibody were evaluated in the kinase assay using synthetic Syk peptide containing S178 as a substrate. (G) THP-1 cells were transfected with vector or Syk (S178A) plasmids for 48 h, followed by PMA treatment and adhesion assay. *p<0.05 as compared to the control PMA response.
Figure 4 Binding domains between Syk and AMPK and AMPK-mediated Syk phosphorylation. (A) HEK293T cells were transfected with Myc-AMPKalpha2 and various deletion constructs of Flag-Syk. Cell lysates were immunoprecipitated with anti-Flag antibody and then subjected to immunoblot analysis with anti-Myc or anti-Flag antibody (upper panel). To assess the association of AMPKalpha2 to different deletions of Syk, we quantified the intensity of immunoprecipitated Syk and associated AMPK. Then the level of AMPK/Syk was calculated (shown in parentheses). Internal controls of Myc-AMPKalpha2 and Flag-Syk expression in cell lysates were determined (lower panel). (B) HEK293T cells were transfected with Myc-AMPKalpha2 and Flag-Syk. Immunoprecipitates using Myc antibody were subjected to immunobloting with Flag antibody. (C) Plasmids of Flag-Syk and Myc-AMPKalpha2 with various deletions were transfected into HEK293T cells. Immunoprecipitates with anti-Flag antibody were subjected to immunoblot analysis with anti-Myc and -Syk antibodies. (D) Alignment of the consensus recognition motifs for AMPK and sequences around sites to be phosphorylated by AMPK on physiological substrates. The serine residues phosphorylated were indicated by the arrow. In the consensus recognition motif, Φ refers to a hydrophobic residue and beta to a basic residue. (E) Myc-AMPKalpha2 was expressed with Flag-Syk (WT) or Flag-Syk (S178A) construct in HEK293T. Afterwards, cells were treated with AICAR for 15 or 30 min. Immunoprecipitate with Syk antibody was then subjected to in vitro kinase assay. In some samples, the presence of Myc-AMPKα2 in immunocomplexes was determined by immunobloting with Myc antibody. (F) THP-1 cells were treated as indicated, and immunocomplexes with AMPK antibody were evaluated in the kinase assay using synthetic Syk peptide containing S178 as a substrate. (G) THP-1 cells were transfected with vector or Syk (S178A) plasmids for 48 h, followed by PMA treatment and adhesion assay. *p<0.05 as compared to the control PMA response.CC BY · PubMed Central
Figure 5 AICAR induces Syk and c-Src activation, and enhances cell adhesion upon PMA stimulation. (A) After treatment with agents as indicated, cell lysates were subjected to immunoblotting. (B) THP-1 cells were co-incubated with AICAR (0.1, 0.5 mM), A769662 (10 µM) and/or PMA (10–100 nM) for 4 h, followed by cell adhesion assay. (C) After expression of active or kinase dead AMPK, THP-1 cells were harvested and tested for the PMA (10, 100 nM)-induced cell adhesion. The expression and activity of AMPK were determined by immunobloting. *p<0.05 as compared to the PMA response without AICAR, A769662, or AMPK adenovirus infection. (D) THP-1 cells were infected with adenovirus expressing constitutively active or kinase-dead AMPK. After 48 h infection, cells were either stimulated with PMA (100 nM) or not for 30 min, and Syk and Src activities were determined by immunoblotting.
Figure 5 AICAR induces Syk and c-Src activation, and enhances cell adhesion upon PMA stimulation. (A) After treatment with agents as indicated, cell lysates were subjected to immunoblotting. (B) THP-1 cells were co-incubated with AICAR (0.1, 0.5 mM), A769662 (10 µM) and/or PMA (10–100 nM) for 4 h, followed by cell adhesion assay. (C) After expression of active or kinase dead AMPK, THP-1 cells were harvested and tested for the PMA (10, 100 nM)-induced cell adhesion. The expression and activity of AMPK were determined by immunobloting. *p<0.05 as compared to the PMA response without AICAR, A769662, or AMPK adenovirus infection. (D) THP-1 cells were infected with adenovirus expressing constitutively active or kinase-dead AMPK. After 48 h infection, cells were either stimulated with PMA (100 nM) or not for 30 min, and Syk and Src activities were determined by immunoblotting.CC BY · PubMed Central
Figure 6 ERK activity independent of AMPK-Syk-Src signaling participates in PKC-mediated monocyte adhesion. (A) After pretreatment with 10 nM GF109203X for 30 min, followed by PMA (100 nM) treatment for 10 min, cell lysates were subjected to immunobloting (left panel). In some experiments, after pretreatment with U0126 and/or compound C for 30 min, THP-1 cells were stimulated with PMA (100 nM) for 4 h, and cell adhesion was determined (middle and right panels). (B–D) THP-1 cells were treated with PMA in the presence of vehicle or pharmacological agents for 10 min (lower panel of B, D) or indicated time periods (upper panel of B, C). Immunobloting with specific antibodies was conducted. FAK activation was determined by immunoprecipitation with FAK-specific antibody and immunoblotting with phospho-tyrosine antibody (D). (E) THP-1 cells pre-labeled with BCECF were treated with SykI, PP2, compound C, U0126 (each at 10 µM), or Ro318220 (3 µM) for 30 min prior to the addition of PMA (100 nM). After 1 h incubation, THP-1 cells were washed with complete medium twice, and then added to HUVEC monolayer grown in 96-well plate. After 1 h, adhesion of THP-1 cells to HUVEC was determined. (F) Human primary monocytes were similarly treated with inhibitors and PMA, and cell adhesion at 4 h was determined. (G) PMA-induced cell adhesion to matrix-coated culture plates, in the absence or presence of alpha5beta1 inhibitor and alphaVbeta3 blocking antibody (LM609), was determined (left panel). In some experiments, after pretreatment with integrin inhibitors for 30 min, THP-1 cells were stimulated with PMA (100 nM) for 4 h, and cell adhesion to either the culture plate or to HUVEC was determined (right panel).
Figure 6 ERK activity independent of AMPK-Syk-Src signaling participates in PKC-mediated monocyte adhesion. (A) After pretreatment with 10 nM GF109203X for 30 min, followed by PMA (100 nM) treatment for 10 min, cell lysates were subjected to immunobloting (left panel). In some experiments, after pretreatment with U0126 and/or compound C for 30 min, THP-1 cells were stimulated with PMA (100 nM) for 4 h, and cell adhesion was determined (middle and right panels). (B–D) THP-1 cells were treated with PMA in the presence of vehicle or pharmacological agents for 10 min (lower panel of B, D) or indicated time periods (upper panel of B, C). Immunobloting with specific antibodies was conducted. FAK activation was determined by immunoprecipitation with FAK-specific antibody and immunoblotting with phospho-tyrosine antibody (D). (E) THP-1 cells pre-labeled with BCECF were treated with SykI, PP2, compound C, U0126 (each at 10 µM), or Ro318220 (3 µM) for 30 min prior to the addition of PMA (100 nM). After 1 h incubation, THP-1 cells were washed with complete medium twice, and then added to HUVEC monolayer grown in 96-well plate. After 1 h, adhesion of THP-1 cells to HUVEC was determined. (F) Human primary monocytes were similarly treated with inhibitors and PMA, and cell adhesion at 4 h was determined. (G) PMA-induced cell adhesion to matrix-coated culture plates, in the absence or presence of alpha5beta1 inhibitor and alphaVbeta3 blocking antibody (LM609), was determined (left panel). In some experiments, after pretreatment with integrin inhibitors for 30 min, THP-1 cells were stimulated with PMA (100 nM) for 4 h, and cell adhesion to either the culture plate or to HUVEC was determined (right panel).CC BY · PubMed Central
Figure 7 A bifurcated signaling pathway is involved in PMA-mediated adhesion of monocytes. PKC can activate LKB1/AMPK, leading to phosphorylation and activation of Syk, then Src and FAK subsequently. PKC-dependent ERK activation induces a coordinated signal for cytoskeleton rearrangement and cell adhesion.
Figure 7 A bifurcated signaling pathway is involved in PMA-mediated adhesion of monocytes. PKC can activate LKB1/AMPK, leading to phosphorylation and activation of Syk, then Src and FAK subsequently. PKC-dependent ERK activation induces a coordinated signal for cytoskeleton rearrangement and cell adhesion.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 45 references

Cited by

See all 54

Metadata

Authors
Chang, M.-Y., Huang, D.-Y., Ho, F.-M., Huang, K.-C., & Lin, W.-W.
Affiliations
  • National Taiwan University (TW)
  • China Medical University (TW)
  • National Taiwan University Hospital (TW)
Corresponding author
Lin, Wan-Wan
Venue
PLoS ONE
Published
2012-07-25
Volume
7
Issue
7
Pages
e40999
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2049709955
Cited by
54
References
45
Citations by year
2026: 1 · 2025: 1 · 2024: 2 · 2023: 6 · 2022: 2 · 2021: 5 · 2020: 5 · 2019: 6 · 2018: 4 · 2017: 5 · 2016: 9 · 2015: 4 · 2014: 3 · 2013: 1
FWCI
1.03
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Science Council (NSC 100-2314-B-002-075)
  • National Health Research Institutes (NHRI-EX100-10052SI)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
  • Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Keywords
monocyte adhesion, protein kinase C, AMPK, Syk, Src kinase, ERK signaling, LKB1, AICAR, THP-1 cells, endothelial cells, focal adhesion kinase, cytoskeleton rearrangement, kinase signaling pathways
MeSH terms
Syk Kinase, AMP-Activated Protein Kinase Kinases, Carcinogens, Cell Adhesion, Cell Line, Cytoskeleton, Energy Metabolism, Enzyme Activation, Humans, Monocytes, Protein Kinase C, Protein-Tyrosine Kinases, Tetradecanoylphorbol Acetate, Protein Serine-Threonine Kinases, src-Family Kinases, MAP Kinase Signaling System, Intracellular Signaling Peptides and Proteins, AMP-Activated Protein Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: PKC-Dependent Human Monocyte Adhesion Requires AMPK and Syk Activation. https://app.cochat.ai/papers/10.1371/journal.pone.0040999
The paper
Chang, M.-Y., Huang, D.-Y., Ho, F.-M., Huang, K.-C., & Lin, W.-W. (2012). PKC-Dependent Human Monocyte Adhesion Requires AMPK and Syk Activation. PLoS ONE. https://doi.org/10.1371/journal.pone.0040999

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.